E8%94%A1%E5%BB%BA%E8%8D%A3%E8%8E%86%E7%94%B0%E9%99%84%E5%B1%9E%E5%8C%BB%E9%99%A2&oword=%E8%94%A1%E
https://zp.shwshr.com/common/job/getJobByJobId.action?jobId=4028c4c28a2af1c9018b8d89e32d34b1https
sitegroup/root/html/4aef1408279926e601279e53eac517a5/fc6e3c83cf2f466895ca8f27af086096.html
81%E5%87%BA%E9%87%8D%E7%82%B9%E3%80%81%E5%9D%87%E8%A1%A1%E5%85%BC%E9%A1%BE%E3%80%81%E7%A7%91%E5%AD%A
非维生素 K 拮抗剂口服抗凝药(NOAC)是房颤患者抗凝治疗的首选药物[1],临床应用中的剂量问题需要重点关注。ENGAGE AF-TIMI 48 研究中,两组患者(高剂量组 60/30 mg
af9c607&chksm=&mpshare=1&scene=23&srcid=0413AAYVVsPLqEKBJg03b0UC&sharer_shareinfo=f44b01db23c28a31fc